Loading...
ProKidney Corp.
PROK•NASDAQ
HealthcareBiotechnology
$0.98
$0.19(24.22%)
ProKidney Corp. (PROK) Financial Performance & Statements
Review ProKidney Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-21.22%
↓ 21.22%
Net Income Growth
-72.51%
↓ 72.51%
Operating Cash Flow Growth
-40.28%
↓ 40.28%
Operating Margin
-60453.59%
↓ 60453.59%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-22362.09%
↓ 22362.09%
ROE
6.94%
↑ 6.94%
ROIC
-49.56%
↓ 49.56%
ProKidney Corp. (PROK) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for ProKidney Corp. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $76000.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | -$1.72M | $0.00 | $964000.00 | $832000.00 |
| Gross Profit | $1.80M | $0.00 | -$964000.00 | -$832000.00 |
| Gross Profit Ratio | $23.63 | $0.00 | ||
| R&D Expenses | $39.78M | $31.25M | $29.40M | $27.23M |
| SG&A Expenses | $12.70M | $17.72M | $13.65M | $12.01M |
| Operating Expenses | $52.48M | $48.97M | $43.06M | $39.24M |
| Total Costs & Expenses | $50.76M | $48.97M | $43.06M | $40.08M |
| Interest Income | $4.79M | $5.58M | $4.54M | $4.84M |
| Interest Expense | $2000.00 | $2000.00 | $3000.00 | $2000.00 |
| Depreciation & Amortization | $1.57M | $1.49M | $964000.00 | $832000.00 |
| EBITDA | -$45.44M | -$42.16M | -$37.55M | -$34.40M |
| EBITDA Ratio | -$597.87 | |||
| Operating Income | -$51.57M | -$48.97M | -$43.06M | -$40.08M |
| Operating Income Ratio | -$678.57 | |||
| Other Income/Expenses (Net) | $4.79M | $5.58M | $4.53M | $4.84M |
| Income Before Tax | -$46.78M | -$43.40M | -$38.52M | -$35.23M |
| Income Before Tax Ratio | -$615.54 | |||
| Income Tax Expense | $1.70M | -$2.34M | -$56000.00 | $98000.00 |
| Net Income | -$21.28M | -$17.91M | -$12.51M | -$9.49M |
| Net Income Ratio | -$279.97 | |||
| EPS | -$0.17 | -$0.14 | -$0.16 | -$0.16 |
| Diluted EPS | -$0.17 | -$0.14 | -$0.16 | -$0.16 |
| Weighted Avg Shares Outstanding | $128.05M | $126.17M | $75.91M | $60.95M |
| Weighted Avg Shares Outstanding (Diluted) | $128.05M | $126.17M | $75.91M | $60.95M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan